**Question:** CA-125 is a marker antigen for the diagnosis of

A. Ovarian cancer
B. Pancreatic cancer
C. Breast cancer
D. Prostate cancer

**Correct Answer:** A. Ovarian cancer

**Core Concept:**
CA-125 is a serum biomarker that is used as a diagnostic tool in oncology, particularly for ovarian cancer. CA stands for Carcinoembryonic Antigen, and these antigens are proteins released from cancerous or damaged cells into the bloodstream. Serum CA-125 levels are elevated in various malignancies, but its primary role is in the detection and monitoring of ovarian cancer.

**Why the Correct Answer is Right:**
CA-125 is a glycoprotein produced by the cells of the fallopian tube, mesothelium, and some ovarian cells. In ovarian cancer, these cells are often damaged or destroyed, leading to the release of CA-125 into the bloodstream. Elevated serum CA-125 levels are thus indicative of ovarian cancer.

**Why Each Wrong Option is Incorrect:**

A. Ovarian cancer is the primary use case for CA-125 testing, but other malignancies and conditions can also cause elevated CA-125 levels, making it unreliable as a standalone diagnostic tool.

B. CA-125 is not specific to pancreatic cancer, as elevated levels can be seen in patients with other conditions like cirrhosis, liver disease, or endometriosis.

C. CA-125 is not specific to breast cancer, as elevated levels can be seen in patients with conditions like endometriosis, ovarian cysts, or pelvic inflammatory disease (PID).

D. CA-125 levels are not specific to prostate cancer, as elevated levels can be seen in patients with conditions like acute pancreatitis, liver disease, or renal failure.

**Clinical Pearl:**
While CA-125 is a valuable tool in monitoring the progression and treatment response of ovarian cancer, it is not a reliable diagnostic marker for ovarian cancer. A combination of clinical presentation, imaging studies, and other biomarkers should be used in conjunction with CA-125 to increase the accuracy of diagnosis and reduce false-positive or false-negative results.